SCHEMBL6576630

SCHEMBL6576630

COc1cccc(Nc2ccc(C)cc2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.65
MTNR1B P49286 6/20 0.64
MTNR1A P48039 4/20 0.64
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
MAPT P10636 2/20 0.59
MAPK1 P28482 2/20 0.59
POLB P06746 1/20 0.59
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
HPGD P15428 1/20 0.55
TP53 P04637 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 2/20 0.54
TSHR P16473 2/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
ACHE P22303 1/20 0.53
TUBB4A P04350 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1921496 0.92 MTNR1B (0.72) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL9479608 0.89 MTNR1B (0.68) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL2112594 0.89 KMT2A (0.71) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL30741242 0.89 KMT2A (0.71) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL9479511 0.89 MTNR1B (0.68) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL30741237 0.89 KMT2A (0.71) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL4544832 0.89 KCNH3 (0.65) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL1085867 0.88 MEN1 (0.71) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL1921418 0.87 MTNR1B (0.66) RAPGEF4MTNR1BMTNR1AMEN1KMT2A
SCHEMBL30080139 0.86 MTNR1B (0.65) RAPGEF4MTNR1BMTNR1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108659050-B Tetradentate ring metal platinum complex containing 6-substituted carbazole, preparation method and application 浙江工业大学 2021-03-09 CN disclosed
US-10808197-B2 Alkylated alkoxydiarylamine antioxidants LANXESS SOLUTIONS US INC. (US) 2020-10-20 US disclosed
US-20190322928-A1 TETRADENTATE CYCLIC-METAL PLATINUM COMPLEXES COMPRISING 6-SUBSTITUTED CARBAZOLE, PRERATION AND USE THEREOF ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2019-10-24 US disclosed
US-20190322928-A1 TETRADENTATE CYCLIC-METAL PLATINUM COMPLEXES COMPRISING 6-SUBSTITUTED CARBAZOLE, PRERATION AND USE THEREOF ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) 2019-10-24 US disclosed
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS LANXESS CORPORATION 2018-03-22 US disclosed
US-7541462-B2 Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-02 US disclosed
US-7541462-B2 Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-02 US disclosed
US-20080139806-A1 TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.. 2008-06-12 US disclosed
US-20080139806-A1 TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.. 2008-06-12 US disclosed
US-7385058-B1 Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-06-10 US disclosed
US-7385058-B1 Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-06-10 US disclosed
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10808197-B2 Alkylated alkoxydiarylamine antioxidants GPX4, CAT, SOD1 RAPGEF4 3728/4885MTNR1B 477/4885MTNR1A 315/4885
US-20080139806-A1 TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION ABL1, AOC1, NPPA RAPGEF4 1735/4885MTNR1B 2111/4885MTNR1A 3361/4885
US-20180079984-A1 ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS GPX4, CAT, SOD1 RAPGEF4 3728/4885MTNR1B 477/4885MTNR1A 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.